Cargando…
25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients
OBJECTIVES: Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064100/ https://www.ncbi.nlm.nih.gov/pubmed/35503795 http://dx.doi.org/10.1371/journal.pone.0268038 |
_version_ | 1784699295706906624 |
---|---|
author | Nguyen, Nguyen N. Raju, Muppala N. P. da Graca, Briget Wang, Dapeng Mohamed, Nada A. Mutnal, Manohar B. Rao, Arundhati Bennett, Monica Gokingco, Matthew Pham, Huy Mohammad, Amin A. |
author_facet | Nguyen, Nguyen N. Raju, Muppala N. P. da Graca, Briget Wang, Dapeng Mohamed, Nada A. Mutnal, Manohar B. Rao, Arundhati Bennett, Monica Gokingco, Matthew Pham, Huy Mohammad, Amin A. |
author_sort | Nguyen, Nguyen N. |
collection | PubMed |
description | OBJECTIVES: Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. METHODS: We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher’s exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. RESULTS: COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53–18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10–6.90]). CONCLUSIONS: There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization. |
format | Online Article Text |
id | pubmed-9064100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90641002022-05-04 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients Nguyen, Nguyen N. Raju, Muppala N. P. da Graca, Briget Wang, Dapeng Mohamed, Nada A. Mutnal, Manohar B. Rao, Arundhati Bennett, Monica Gokingco, Matthew Pham, Huy Mohammad, Amin A. PLoS One Research Article OBJECTIVES: Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. METHODS: We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher’s exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. RESULTS: COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53–18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10–6.90]). CONCLUSIONS: There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization. Public Library of Science 2022-05-03 /pmc/articles/PMC9064100/ /pubmed/35503795 http://dx.doi.org/10.1371/journal.pone.0268038 Text en © 2022 Nguyen et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Nguyen, Nguyen N. Raju, Muppala N. P. da Graca, Briget Wang, Dapeng Mohamed, Nada A. Mutnal, Manohar B. Rao, Arundhati Bennett, Monica Gokingco, Matthew Pham, Huy Mohammad, Amin A. 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients |
title | 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients |
title_full | 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients |
title_fullStr | 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients |
title_full_unstemmed | 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients |
title_short | 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients |
title_sort | 25-hydroxyvitamin d is a predictor of covid-19 severity of hospitalized patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064100/ https://www.ncbi.nlm.nih.gov/pubmed/35503795 http://dx.doi.org/10.1371/journal.pone.0268038 |
work_keys_str_mv | AT nguyennguyenn 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT rajumuppalanp 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT dagracabriget 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT wangdapeng 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT mohamednadaa 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT mutnalmanoharb 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT raoarundhati 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT bennettmonica 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT gokingcomatthew 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT phamhuy 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients AT mohammadamina 25hydroxyvitamindisapredictorofcovid19severityofhospitalizedpatients |